Literature DB >> 23001986

Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism.

Daniel Antonio de Luis1, Gonzalo Diaz Soto, Rosa Conde, Olatz Izaola, Beatriz de la Fuente.   

Abstract

BACKGROUND: Primary hyperparathyroidism (PHPT) is associated with high cardiovascular morbidity. The aim of the present study was to explore the relationship of leptin and adiponectin levels with cardiovascular risk factors and anthropometric parameters in patients with PHTP with and without metabolic syndrome (MS).
METHODS: A total of 62 patients with PHPT were enrolled. Weight, blood pressure, basal glucose, insulin, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, insulin, HOMA-R, intact parathormone, vitamin D, calcium, leptin, and adiponectin levels were measured in fasting condition.
RESULTS: Prevalence of MS with ATP III definition was 32.3% (20 patients; 15 females (75%) and 5 males (25%)) and 67.7% patients without MS (n = 42 patients; 35 females (83.3%) and 7 males (16.7%)). In the analysis with leptin as dependent variable, the weight and HOMA-R levels remained in the model (F = 9.2; P < 0.05), with an increase of 1.31 (CI 95%: 0.24-2.31) ng/ml with each one unit of HOMA-R and an increase of 0.4 (CI 95%: 0.01-0.84) ng/ml with each 1 kg of weight. In a second model with adiponectin as dependent variable, the HOMA-R and HDL-cholesterol levels remained in the model (F = 7.37; P < 0.05), with a decrease of -0.62 (CI 95%: 0.01-1.1) ng/ml with each one point of HOMA-R and an increase of 0.18 (CI 95%: 0.04-0.38) ng/ml with each 1 mg/dl of HDL-cholesterol. In the multivariate, PTH I was not associated with other variables.
CONCLUSION: There was a high prevalence of MS-32.3% of patients with PHPT presented an MS. Serum levels of leptin and adiponectin are not related with PTH I, vitamin D, and calcium levels in patients with PHPT.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001986      PMCID: PMC6807524          DOI: 10.1002/jcla.21541

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  17 in total

Review 1.  Does body mass play a role in the regulation of food intake?

Authors:  John R Speakman; R James Stubbs; Julian G Mercer
Journal:  Proc Nutr Soc       Date:  2002-11       Impact factor: 6.297

Review 2.  Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease.

Authors:  E L Kaplan; T Yashiro; G Salti
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

3.  Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism.

Authors:  Enrica Delfini; Luigi Petramala; Chiara Caliumi; Darlo Cotesta; Giorgio De Toma; Giuseppe Cavallaro; Giuseppe Panzironi; Daniele Diacinti; Savatore Minisola; Emilio D' Erasmo; Gian Franco Mazzuoli; Claudio Letizia
Journal:  Metabolism       Date:  2007-01       Impact factor: 8.694

4.  Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism.

Authors:  C Letizia; P Ferrari; D Cotesta; C Caliumi; R Cianci; S Cerci; L Petramala; M Celi; S Minisola; E D'Erasmo; G F Mazzuoli
Journal:  J Hum Hypertens       Date:  2005-11       Impact factor: 3.012

5.  Leptin and biochemical markers of bone turnover in dialysis patients.

Authors:  Carmine Zoccali; Vincenzo Panuccio; Giovanni Tripepi; Sebastiano Cutrupi; Patrizia Pizzini; Francesca Mallamaci
Journal:  J Nephrol       Date:  2004 Mar-Apr       Impact factor: 3.902

6.  Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis.

Authors:  Morihiro Matsuda; Iichiro Shimomura; Masataka Sata; Yukio Arita; Makoto Nishida; Norikazu Maeda; Masahiro Kumada; Yoshihisa Okamoto; Hiroyuki Nagaretani; Hitoshi Nishizawa; Ken Kishida; Ryutaro Komuro; Noriyuki Ouchi; Shinji Kihara; Ryozo Nagai; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Biol Chem       Date:  2002-07-22       Impact factor: 5.157

7.  Increased risk of death from primary hyperparathyroidism--an update.

Authors:  G Hedbäck; A Odén
Journal:  Eur J Clin Invest       Date:  1998-04       Impact factor: 4.686

8.  Assessment of fat-free mass using bioelectrical impedance measurements of the human body.

Authors:  H C Lukaski; P E Johnson; W W Bolonchuk; G I Lykken
Journal:  Am J Clin Nutr       Date:  1985-04       Impact factor: 7.045

9.  Serum leptin in dialysis renal osteodystrophy.

Authors:  Giorgio Coen; Paola Ballanti; Maria Stephanie Fischer; Alessandro Balducci; Santo Calabria; Luisa Colamarco; Giacomo Di Zazzo; Francesca Lifrieri; Micaela Manni; Daniela Sardella; Italo Nofroni; Ermanno Bonucci
Journal:  Am J Kidney Dis       Date:  2003-11       Impact factor: 8.860

Review 10.  Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin.

Authors:  Ursula Meier; Axel M Gressner
Journal:  Clin Chem       Date:  2004-07-20       Impact factor: 8.327

View more
  9 in total

Review 1.  The intriguing connections of leptin to hyperparathyroidism.

Authors:  Stergios A Polyzos; Leonidas Duntas; Jens Bollerslev
Journal:  Endocrine       Date:  2017-07-20       Impact factor: 3.633

2.  The parathyroid leptin axis.

Authors:  Jaya George
Journal:  Endocrine       Date:  2017-04-28       Impact factor: 3.633

3.  Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms.

Authors:  M Procopio; M Barale; S Bertaina; S Sigrist; R Mazzetti; M Loiacono; G Mengozzi; E Ghigo; M Maccario
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

Review 4.  Vitamin D and serum leptin: a systematic review and meta-analysis of observational studies and randomized controlled trials.

Authors:  M Hajimohammadi; S Shab-Bidar; T R Neyestani
Journal:  Eur J Clin Nutr       Date:  2016-12-14       Impact factor: 4.016

5.  Visceral adiposity is a predictor of parathyroid hormone levels in healthy adults.

Authors:  J A George; S A Norris; M Toman; T Snyman; N J Crowther
Journal:  J Endocrinol Invest       Date:  2015-10-26       Impact factor: 4.256

6.  High prevalence of metabolic syndrome in a mestizo group of adult patients with primary hyperparathyroidism (PHPT).

Authors:  Victoria Mendoza-Zubieta; Gloria A Gonzalez-Villaseñor; Guadalupe Vargas-Ortega; Baldomero Gonzalez; Claudia Ramirez-Renteria; Moises Mercado; Mario A Molina-Ayala; Aldo Ferreira-Hermosillo
Journal:  BMC Endocr Disord       Date:  2015-04-03       Impact factor: 2.763

7.  Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.

Authors:  Leon Fisher; Wichat Srikusalanukul; Alexander Fisher; Paul Smith
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

8.  Association between Vitamin D and Adiponectin and Its Relationship with Body Mass Index: The META-Health Study.

Authors:  Aurelian Bidulescu; Alanna A Morris; Neli Stoyanova; Yuan-Xiang Meng; Viola Vaccarino; Arshed A Quyyumi; Gary H Gibbons
Journal:  Front Public Health       Date:  2014-10-14

9.  Obesity, adipose tissue function and the role of vitamin D.

Authors:  Aneta U Koszowska; Justyna Nowak; Anna Dittfeld; Anna Brończyk-Puzoń; Agata Kulpok; Barbara Zubelewicz-Szkodzińska
Journal:  Cent Eur J Immunol       Date:  2014-06-27       Impact factor: 2.085

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.